Genetic Health Service Provider, Panacea, Launches to Make Whole Exome Sequencing Accessible to Consumers Without Insurance Barriers
PALM BEACH, Fla., Feb. 28, 2024 /PRNewswire/ -- Panacea, the one-stop-shop for genetic health services making potentially life-saving testing accessible for consumers, today announced its nationwide* commercial availability, without needing to visit a doctor or receive approval from insurance.
- The problem is that current guidelines for doctors to order genetic tests, and for insurance to approve it, are missing about half of the people with genetic mutations.
- "I had my exome sequenced with Panacea, even though I was not a candidate for testing based on today's medical guidelines.
- This further inspired me to make clinical-grade whole exome sequencing more accessible, so everyone can make informed decisions about their future."
- For more information on Panacea or on whole exome sequencing, please visit seekpanacea.com .